Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011–2016

OBJECTIVES: To describe (i) the trend in oral anticoagulant (OAC) use following the introduction of non-vitamin K antagonist oral anticoagulant (NOAC) therapy for stroke prevention in atrial fibrillation (AF) patients and (ii) the current patterns of use of NOAC therapy in new users with AF in Franc...

Descripción completa

Detalles Bibliográficos
Autores principales: Maura, Géric, Billionnet, Cécile, Drouin, Jérôme, Weill, Alain, Neumann, Anke, Pariente, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500377/
https://www.ncbi.nlm.nih.gov/pubmed/31005934
http://dx.doi.org/10.1136/bmjopen-2018-026645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500377/
https://www.ncbi.nlm.nih.gov/pubmed/31005934
http://dx.doi.org/10.1136/bmjopen-2018-026645

Ejemplares similares